Atlas Trials

Olaparib for the Treatment of Castration Resistant Prostate Adenocarcinoma

Clinical trial NCT04951492 · TERMINATED

Trial details

NCT number
NCT04951492
Sponsor
University of Washington
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Castration-Resistant Prostate CarcinomaProstate Adenocarcinoma
Start date
2022-11-09
Primary completion
2023-10-15
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.